FDA reviewing heart risks of Glaxo diabetes pill Avandia

Expiry-drugs1

The Food and Drug Administration will hold a meeting in June to reassess the safety of GlaxoSmithKline’s former blockbuster diabetes drug Avandia.

Read more

Posted in Drugs